Login

Consolidated balance sheet

In millions of USD, except per-share amounts
Q2 FY2025
As of Jun 28, 2025
Q1 FY2025
As of Mar 29, 2025
Q4 FY2024
As of Dec 28, 2024
Q3 FY2024
As of Sep 28, 2024
Q2 FY2024
As of Jun 29, 2024
Q1 FY2024
As of Mar 30, 2024
Q4 FY2023
As of Dec 30, 2023
Q3 FY2023
As of Sep 30, 2023
Current assets
Cash and cash equivalents
Accounts receivable, net
Related Party
Total accounts receivable, net
Inventories
Other current assets
Total current assets
Property, net
Operating lease right-of-use assets
Goodwill
Other intangibles
Postretirement plan assets
Other assets
Total assets
Current liabilities
Notes payable
Current maturities of long-term debt
Accounts payable
Related Party
Total accounts payable
Accrued advertising and promotion
Accrued salaries and wages
Other current liabilities
Related Party
Nonrelated Party
Total other current liabilities
Total current liabilities
Long-term debt
Long-term operating lease obligations
Deferred income taxes
Pension liability
Nonpension postretirement liability
Other liabilities
Equity
Common stock, $0.0001 par value, 1,000,000,000 shares authorized Issued: 86,240,872 shares as of June 28, 2025 and 86,101,154 shares as of December 28, 2024
Net parent investment
Capital in excess of par value
Retained earnings
Accumulated other comprehensive loss
Total equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support